MAT2A (methionine adenosyltransferase 2A)

symbol:
MAT2A
locus group:
protein-coding gene
location:
2p11.2
gene_family:
alias symbol:
SAMS2|MATA2|MATII
alias name:
None
entrez id:
4144
ensembl gene id:
ENSG00000168906
ucsc gene id:
uc002spr.4
refseq accession:
NM_005911
hgnc_id:
HGNC:6904
approved reserved:
1997-07-01
2p11.2

MAT2A(甲硫氨酸腺苷转移酶2A)是甲硫氨酸代谢途径中的关键酶,属于甲硫氨酸腺苷转移酶(MAT)基因家族。该家族包括MAT1A、MAT2A和MAT2B三个成员,主要功能是催化甲硫氨酸(Met)与ATP反应生成S-腺苷甲硫氨酸(SAMe),这是体内重要的甲基供体,参与DNA甲基化、多胺合成和磷脂代谢等关键生物学过程。MAT2A主要在增殖活跃的细胞(如胚胎组织、肝脏外组织和癌细胞)中表达,而MAT1A主要在成熟肝脏中表达。MAT2A的突变可能导致SAMe水平异常,影响甲基化反应和细胞增殖,与多种疾病相关,包括肝病、心血管疾病和癌症。MAT2A过表达会提高SAMe水平,促进细胞增殖和肿瘤发生,尤其在肝癌中表现明显;而降低表达则会导致SAMe不足,影响甲基化过程,可能引发肝损伤或发育缺陷。MAT2A在癌症中常因高代谢需求而上调,成为潜在的治疗靶点。此外,MAT2A与MAT2B形成复合物调节酶活性,其表达失衡可能影响其他代谢基因(如GNMT)的功能。该基因家族成员的共性是参与甲硫氨酸循环,维持甲基化稳态,但组织分布和调控机制存在差异。

中文English

由该基因编码的蛋白质催化从蛋氨酸和ATP生产的S-腺苷甲硫氨酸(的AdoMet)的。的AdoMet是在细胞过程的关键甲基供体。 [由RefSeq的,2011年6月提供]

MAT2A基因的碱基序列:[NCBI]
Loading Gene Browser...
蛋白质序列
1MNGQLNGFHE AFIEEGTFLF TSESVGEGHP DKICDQISDA
41VLDAHLQQDP DAKVACETVA KTGMILLAGE ITSRAAVDYQ
81 KVVREAVKH IGYDDSSKGF DYKTCNVLVA LEQQSPDIAQ
121GVHLDRNEED IGAGDQGLMF GYATDETEEC MPLTIVLAHK
161L NAKLAELR RNGTLPWLRP DSKTQVTVQY MQDRGAVLPI
201RVHTIVISVQ HDEEVCLDEM RDALKEKVIK AVVPAKYLDE
241DT IYHLQPS GRFVIGGPQG DAGLTGRKII VDTYGGWGAH
281GGGAFSGKDY TKVDRSAAYA ARWVAKSLVK GGLCRRVLVQ
321VSY AIGVSH PLSISIFHYG TSQKSERELL EIVKKNFDLR
361PGVIVRDLDL KKPIYQRTAA YGHFGRDSFP WEVPKKLKY
结构预测来自 AlphaFold DB(UniProt: P31153),颜色表示 pLDDT 置信度(深蓝高、黄橙低)。
MAT2A基因的碱基突变:           仅显示部分snp
rs1050108       rs1867880       rs3209939       rs7605975       rs62165899       rs113066451       rs138686161       rs143021753       rs144074011       rs144911618       rs149495444       rs184837848       rs189173899       rs189711755       rs193153527       rs370014861       rs371101314      

MAT2A基因在不同组织中的表达:    [UniProt]

基因在不同组织中的表达图
正向引物序列
正向Tm值
反向引物序列
反向Tm值
评分
CCACCCAGATAAGATTTGTGAC
59
AAGCTACTTTGGCATCAGGA
60
GTACCTCTCAGAAGAGTGAGAG
59
ATCCAGATCCCTGACAATGAC
60
CCACCCAGATAAGATTTGTGAC
59
AAGCTACTTTGGCATCAGGA
60
TGACCAAATCAGTGATGCT
57
TTAGCAACAGTTTCACAAGC
57
GTCACCAGATATTGCTCAAGG
59
CCAAACATTAAGCCCTGGTC
59
TTCTTGTTCAGGTCTCTTATGC
59
TCTTCTGAGAGGTACCATAATGG
59
GTCACCAGATATTGCTCAAGG
58
CCAAACATTAAGCCCTGGTC
59
GGTCGCTAATAAGATTTGTGACC
60
AAGCTACTTTGGCATCAGGA
60
GGTACCTCTCAGAAGAGTGAG
59
TCCAGATCCCTGACAATGAC
59
GTGGTCGCTAATAAGATTTGTG
58
CTACTTTGGCATCAGGATCC
58
转录因子
影响基因
影响类型
参考文献链接(PubMed)
JUN
MAT2A
Activation
MYB
MAT2A
Activation
MYB
MAT2A
Unknown
NFKB1
MAT2A
Activation
RELA
MAT2A
Activation
SP1
MAT2A
Activation
SP1
MAT2A
Unknown
SP2
MAT2A
Unknown
SP3
MAT2A
Unknown

MAT2A基因(以及对应的蛋白质)的细胞分布位置:

[UniProt]     [GenomeNet]

" d="M482.414,245.296c3.539,4.293,4.455,10.009,0.202,11 c-4.244,0.996-4.983-10.983-8.293-8.438c-5.271,4.08,9.834,12.271,5.144,17.287c-3.717,3.607-6.172-5.75-10.839-1.976 c-4.673,3.776,6.781,7.299,2.831,11.326c-4.354,4.045-6.979-1.449-9.837-5.517c-1.193-1.742-2.059-3.851-3.595-2.748 c-1.516,1.078-1.854,1.795-0.938,3.666c2.374,4.854,9.235,10.119,5.156,12.535c-5.636,3.346-5.044-8.871-9.426-7.574 c-4.388,1.291,2.557,10.66-1.245,11.141c-4.089,0.545-3.483-10.239-6.979-8.575c-2.522,1.206-0.929,3.071-0.938,4.899 c0.004,1.32-0.964,3.6-2.372,4.062c-3.593,1.171-8.544-1.065-10.251-3.59c-6.04-8.93,0.396-15.997,4.639-7.015 c3.023,4.642,5.182,0.834,2.839-2.219c-1.032-1.354-4.309-5.901-0.781-7.252c2.904-1.113,4.271,1.941,5.985,4.592 c2.61,4.016,5.485,0.117,3.031-3.414c-1.828-2.633-2.74-3.803,3.156-7.42c6.405-4.369,6.52,3.869,10.077,0.646 c2.309-1.832-4.783-5.149,0.06-8.995c2.896-2.293,5.18,6.207,7.961,3.516c3.523-2.737-7.717-7.369,0.117-11.736 C473.413,240.77,480.519,242.891,482.414,245.296z"/> Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
  • 质膜
  • 细胞质
  • 细胞外
  • 高尔基体
  • 囊泡
  • 细胞骨架
  • 内质网
  • 细胞核
  • 内体
  • 溶酶体
  • 线粒体

MAT2A基因的本体(GO)信息:

GO库代码
对应的蛋白质
来源代码
GO:0004478
P31153 (UniProtKB)
IDA
GO:0004478
P31153 (UniProtKB)
IDA
GO:0005515
P31153 (UniProtKB)
IPI
GO:0005515
P31153 (UniProtKB)
IPI
GO:0005524
P31153 (UniProtKB)
IEA
GO:0005829
P31153 (UniProtKB)
IBA
GO:0005829
P31153 (UniProtKB)
TAS
GO:0006556
P31153 (UniProtKB)
IEA
GO:0006556
P31153 (UniProtKB)
IDA
GO:0006730
P31153 (UniProtKB)
IEA
GO:0032259
P31153 (UniProtKB)
TAS
GO:0046872
P31153 (UniProtKB)
IEA
GO:0048269
P31153 (UniProtKB)
IDA

可能调控 MAT2A基因的相关microRNA:     

String
BioGrid
IntAct
mentha
Reactome
加载中…
关联基因 作用方式 资源库来源/分值
疾病名称 关系值 NofPmids NofSnps 来源
疾病名称 关系值 NofPmids NofSnps 来源
IGA Glomerulonephritis 0.12 1 0 CTD_human
Liver carcinoma 0.005981653 12 0 BeFree_LHGDN
Spina Bifida 0.004734064 2 0 GAD
Liver neoplasms 0.003538676 4 0 BeFree_LHGDN
Colonic Neoplasms 0.00272435 1 0 LHGDN
Cleft Lip 0.002367032 1 0 GAD
Cleft Palate 0.002367032 1 0 GAD
Mammary Neoplasms 0.002367032 1 0 GAD
Colorectal Cancer 0.002367032 1 0 GAD
Malignant neoplasm of liver 0.001628651 6 0 BeFree
Real-World Prevalence and Structural Validation of the Canonical 9p21 MTAP-CDKN2A/B Deletion in Non-NSCLC Solid Tumors.
Han M, Lee E, Shin JE, Kwon M, Hong JY, Kim ST, Ahn S, Kim KM, Lee J, Lim SH Cancers (Basel) 2026-03-10
Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategies.
Bevilacqua R, Gasperini P, Cantore T, Macedo-Silva C, Pancher M, Radić M, Yue H, Quaini O, Fedrizzi T, Gatto P, Seiler R, Kiss B, Adami V, Lorenzin F, Kruithof-de Julio M, Faltas BM, Demichelis F NPJ Precis Oncol 2026-04-18
Coupled-enzyme assay for MTAP activity in biological samples.
Gilaj N, Wagner AG, Li T, Dedushi D, Eskandari R, Kuang C, Schramm VL Anal Biochem IF: 3.1 2026-07-00
Unraveling the potential of targeting methionine metabolism in cancer.
Wang BQ, Li XC, Huo Z, Zeng K, Chen S, Wang Y, Zhu Y, Huang Y, Ding J, Cai Y, Li N, Tang Y Cancer Lett IF: 11.8 2026-04-28
Novel Synthetic Lethal Therapeutic Strategies in Precision Oncology.
Yap TA, Simpkins F, Porte M, Postel-Vinay S Am Soc Clin Oncol Educ Book 2026-06-00
The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.
Vokes NI, Symons JL, Rhead B, Hong L, Shah PA, Lai Z, Zhu Z, Treviño S, Bryan J, Wu J, Zhang J, Gibbons D, Heymach JV, Stewart R, Iyer S, Leventakos K, Fragkogianni S, Chao C, Rodon JA Clin Cancer Res IF: 10.9 2026-07-27
Acetoacetate-GPR43 axis epigenetically silences IL-6/CSF1 to restrict TAMs-driven metastatic lung cancer.
Yuan S, Xiao B, Ni S, Liu W, Hou M, Jiang Y, Jia L J Transl Med IF: 3.786 2026-08-03
Discovery of a Potent, Selective, and Orally Bioavailable Achiral MAT2A Inhibitor for Treating MTAP-Deficient Cancers.
Lin L, Xie Z, Liu J, Fan Z, Shi Z, Sun Y, Lin K, Cui R, Jiang X, Luo X, Zhang S, Zheng M, Xu S J Med Chem IF: 7.3 2026-08-13
Carrier-Free Nanoparticles Enhance Photothermal-Immune Therapy via Metabolic Reprogramming in Triple-Negative Breast Cancer.
Hou Y, Cheng Y, Lin Y, Sheng H, Mao X, Li Z, Ye Z, Wang L, Kang Y, Ye J, Yao Q, Kou L, Bao S, Chen R Adv Healthc Mater IF: 11.0 2026-08-00

评论加载中...

登录后即可发表评论 登录 注册

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: [email protected]